Brought to you by 
Tesaro nets $80.7mm through IPO
26 Jul 2012
Executive Summary
Just two years after Tesaro Inc. was launched by former MGI Pharma executives, the oncology firm has completed its initial public offering. The company sold 6.4mm shares (including the overallotment)at $13.50 each, in line with its intended $12-15 range.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tesaro nets $80.7mm through IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice